TORONTO, Feb. 03, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into a research collaboration agreement with PharmaTher Holdings Ltd. (“PharmaTher”) (OTCQB…


Previous articleAustralia Recognises MDMA and Psilocybin as Medicines
Next articlePsychedelics Weekly – Research Explained: Ketamine and the Corticothalamic Network, Psilocybin and the Immune System, & Canalization and Plasticity